A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3

NCT00001064 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Allogenic Dendritic Cells

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)